Edward Korycka Email

Clinical Field Director . Access Vascular

Current Roles

Employees:
59
Revenue:
$7.4M
About
Access Vascular is developing a suite of venous access devices that use our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access. Our first product, FDA-cleared HydroPICC, has demonstrated a 30x reduction in thrombosis versus a standard polyurethane catheter.* *Data on file at Access Vascular. Reduction of thrombosis accumulation was evaluated using in vitro and in vivo models.
Access Vascular Address
749 Middlesex Turnpike
Bedford, MA
United States
Access Vascular Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.